EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prostaglandin‐E1 infusion in persistent pulmonary hypertension of the newborn

Stephanie M Tsoi iD, Hythem Nawaytou, Hassan Almeneisi, Martina Steurer, Yili Zhao, Jeffrey R Fineman, Roberta L Keller

Pediatric Pulmonology · 2024-02 · 59 (2) · 379-388

DOI: 10.1002/ppul.26759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 17.11.2023. Verfasst von Stephanie M Tsoi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Critical Care Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Persistent Fetal Circulation Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonates with persistent pulmonary hypertension of the newborn (PPHN) can present with hypoxia and right ventricular dysfunction with resultant inadequate oxygen delivery and end‐organ damage. This study describes the use of prostaglandin‐E1 (PGE) for ductal patency to preserve right ventricular systolic function and limit afterload in newborns with PPHN.

Methods

This is a retrospective cohort study that follows the hemodynamics, markers of end‐organ perfusion, length of therapeutics, and echocardiographic variables of 57 newborns who used prostglandin‐E1 in the setting of PPHN.

Results

Tachycardia, lactic acidosis, and supplemental oxygen use improved following PGE initiation. Fractional area change (FAC), to assess right ventricular systolic function, and pulmonary arterial acceleration time indexed to right ventricular ejection time (PAAT/RVET), to assess right ventricular afterload, also improved over three time points relative to PGE use (before, during, and after).

Conclusions

Overall, we described the safety and utility of PGE in newborns with severe PPHN for stabilization while allowing natural disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryPersistent Fetal Circulation SyndromeHumansInfant, NewbornRetrospective StudiesProstaglandinsOxygen

Stichwörter der Autor:innen

echocardiographyhypoxic respiratory failurepulmonary vascular resistancepulmonary vasodilator

Substanzen

ProstaglandinsOxygen

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Critical Care Medicine, University of California San Francisco, San Francisco, California, USA.
  • Department of Pediatrics, Division of Cardiology, University of California San Francisco, San Francisco, California, USA.
  • Department of Pediatrics, Division of Neonatology, University of California San Francisco, San Francisco, California, USA.
  • Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
  • Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Stephanie M Tsoi

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Tsoi, S. M., Nawaytou, H., Almeneisi, H., Steurer, M., Zhao, Y., Fineman, J. R., & Keller, R. L. (2024). Prostaglandin‐E1 infusion in persistent pulmonary hypertension of the newborn. Pediatric Pulmonology, 59(2), 379-388. https://doi.org/10.1002/ppul.26759

Vancouver

Tsoi SM, Nawaytou H, Almeneisi H, Steurer M, Zhao Y, Fineman JR, et al. Prostaglandin‐E1 infusion in persistent pulmonary hypertension of the newborn. Pediatric Pulmonology. 2024;59(2):379-388. doi:10.1002/ppul.26759

BibTeX
@article{Tsoi2024,
  author = {Tsoi, Stephanie M and Nawaytou, Hythem and Almeneisi, Hassan and Steurer, Martina and Zhao, Yili and Fineman, Jeffrey R and Keller, Roberta L},
  title = {Prostaglandin‐E1 infusion in persistent pulmonary hypertension of the newborn},
  journal = {Pediatric Pulmonology},
  year = {2024},
  volume = {59},
  number = {2},
  pages = {379--388},
  doi = {10.1002/ppul.26759}
}
Kostenlos starten →